Recent neuroimaging studies have revealed that hyperactivity is the primary neuronal dysfunction in early AD, and may further exacerbate disease progression by increasing the release of amyloid β and tau protein [12–14]. This evidence concerns the gene MAPT and Alzheimer disease.